SCHEMBL13575267

SCHEMBL13575267

C/N=C(\N)c1ccc(-c2oc(-c3ccc(C(=N)N)cc3)c(C)c2C)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO2 P16083 9/20 0.78
▸ ALDH1A1 P00352 1/20 0.46
▸ TOP1 P11387 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ CASP1 P29466 1/20 0.46
▸ CASP7 P55210 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ PRMT1 Q99873 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ TOP2A P11388 1/20 0.45
▸ TOP2B Q02880 1/20 0.45
▸ F2 P00734 4/20 0.43
▸ F10 P00742 3/20 0.43
▸ WDR5 P61964 1/20 0.41
▸ MASP2 O00187 1/20 0.40
▸ PLAU P00749 1/20 0.40
▸ THPO P40225 1/20 0.40
▸ PRSS1 P07477 1/20 0.39
▸ APEX1 P27695 1/20 0.39
▸ PRSS3 P35030 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL549141 0.88 NQO2 (1.00) NQO2ALDH1A1TOP1HPGDCASP1
SCHEMBL13573621 0.81 NQO2 (0.83) NQO2ALDH1A1TOP1HPGDCASP1
SCHEMBL6750104 0.74 NQO2 (0.72) NQO2ALDH1A1TOP1HPGDCASP1
SCHEMBL19309697 0.69 NQO2 (0.61) NQO2ALDH1A1TOP1HPGDCASP1
SCHEMBL27639231 0.69 NQO2 (0.64) NQO2ALDH1A1TOP1HPGDCASP1
SCHEMBL15653057 0.67 MASP2 (0.48) ALDH1A1CASP1HSD17B10TDP1F2
SCHEMBL25914317 0.67 CYP2D6 (0.55) ALDH1A1HPGDPLAU
SCHEMBL14339598 0.66 GRIN2B (0.56) HPGDHSD17B10TDP1WDR5
SCHEMBL394218 0.66 WDR5 (0.80) NQO2ALDH1A1TOP1HPGDCASP1
SCHEMBL8973288 0.66 WDR5 (0.80) NQO2ALDH1A1TOP1HPGDCASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090298934-A1 Diamidine Inhibitors of TDP1 GOVERNMENT OF THE US, AS REPRESENTED BY THE SECRET (US) 2009-12-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298934-A1 Diamidine Inhibitors of TDP1 TDP1, TDP2, DTD1 NQO2 384/4885ALDH1A1 1259/4885TOP1 105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback